Sansure Biotech Inc. (688289.SH) plans to repurchase shares with an amount ranging from 50 million to 100 million yuan.
Shengxiang Biology (688289.SH) announced that the company plans to repurchase shares ranging from 50 million to 100 million RMB, with a repurchase price not exceeding 22 RMB per share. The repurchased shares will be used in the future at a suitable time for an employee stock ownership plan or equity incentive.
Sansure Biotech Inc. (688289.SH) announced that the company plans to repurchase shares worth 50 million to 100 million yuan. The repurchase price will not exceed 22 yuan per share, and the repurchased shares will be used in the future for employee stock ownership plans or equity incentives at the appropriate time.
Related Articles
On June 23, JF SMARTINVEST (09636) spent approximately 2.023 million Hong Kong dollars to repurchase 73,500 shares.
On June 23, JD Health (06618) spent 16.65 million Hong Kong dollars to repurchase 500,000 shares.
CHINA XLX FERT (01866) appoints Chen Weixian as an independent non-executive director.
On June 23, JF SMARTINVEST (09636) spent approximately 2.023 million Hong Kong dollars to repurchase 73,500 shares.
On June 23, JD Health (06618) spent 16.65 million Hong Kong dollars to repurchase 500,000 shares.
CHINA XLX FERT (01866) appoints Chen Weixian as an independent non-executive director.
RECOMMEND
